EW:NYSE
Edwards Lifesciences Corp
86,53 USD
arrow_upward
+0,23%(+0,19) 1 D
1. okt., 09:40:04 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EW …
Åpne
85,99 USD
Høy
86,81 USD
Lav
85,99 USD
Markedsverdi
49,88 mrd.
Snittvolum
3,24 mill.
Volum
303,00
P/E-forhold
50,06
52 u høy
96,29 USD
52 u lav
72,30 USD
EPS
1,73 USD
Beta
0,85
Utestående aksjer
576,40 mill.
Antall ansatte
16k
Åpne
85,99 USD
Høy
86,81 USD
Lav
85,99 USD
Markedsverdi
49,88 mrd.
Snittvolum
3,24 mill.
Volum
303,00
P/E-forhold
50,06
52 u høy
96,29 USD
52 u lav
72,30 USD
EPS
1,73 USD
Beta
0,85
Utestående aksjer
576,40 mill.
Antall ansatte
16k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 1 time siden
VOO og SPY: Topp 3 katalysatorer for S&P 500-ETF-er i oktober
Invezz
·
for 1 døgn siden
Dow faller 130 poeng etter at amerikanske statsrenter når flerårige høyder
markets.businessinsider.com
·
for 24 minutter siden
Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Om Edwards Lifesciences Corp
Administrerende direktør-
Ansatte16k
Grunnlagt1958
HovedkontorIrvine, California, USA
Sektor-
Nettstededwards.com